MedPath

Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal

Not Applicable
Completed
Conditions
Screening
Cervical Cancer
Stigma
Interventions
Behavioral: "Cervical Cancer Stigma Reduction Intervention"
Registration Number
NCT05489978
Lead Sponsor
Kathmandu University School of Medical Sciences
Brief Summary

It is a cluster randomized control trial to assess the effectiveness of the cervical cancer stigma reduction intervention on cancer stigma score and cervical cancer screening uptake in Nepal

Detailed Description

Despite the presence of ample evidence, that stigma is one of the major reasons for low screening coverage, Nepal does not have a single stigma reduction intervention targeted among women to increase cervical cancer screening coverage. Therefore, we aim to assess the effectiveness of a stigma reduction education program on stigma score and cervical cancer screening uptake in Nepal. We will conduct a two-arm open-label cluster-interventional study in Budanilkhantha Municipality. A computer-based program will randomly allocate the 12 wards of Budanilkhantha Municipality with an allocation ratio 1:1; 6 wards in intervention group and 6 wards in control group. We will conduct a "stigma reduction education program" in the intervention group. After that we will follow up the participants for2 months to see the effectiveness of a stigma reduction education program on stigma score and cervical cancer screening uptake in Nepal. We will analyze data using STATA 14. We will use independent tests to find the mean difference between cervical cancer screening uptake and cervical cancer stigma score. The difference in mean among the two groups will actually be the difference due to intervention given. Findings from this study will help managers and stakeholders to formulate and improve strategies on screening programs and develop programs to reduce stigma on cervical cancer among women in Nepal.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
310
Inclusion Criteria
  • Women aged 30-60 years (the age range recommended for VIA screening in Nepal
  • Married women
  • Residents of Budanilkantha Municipality
Read More
Exclusion Criteria
  • Women who have already undergone screening within 5 years.
  • Women with hearing or mental disorders
  • Pregnant women
  • Less than 6 weeks postpartum
  • Mothers who had lived in the community for less than 6 months to perform seasonal work (e.g. in brick kilns) or visitors in the family.
  • Women who are already diagnosed with cervical pre-cancer and cancer and have undergone hysterectomy.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention Arm"Cervical Cancer Stigma Reduction Intervention"Randomization will allocate women to intervention and control arm in 1:1 ratio; with 6 wards in each group. The intervention arm will consist of 153 women who will receive "Cervical Cancer Stigma Reduction Intervention".
Primary Outcome Measures
NameTimeMethod
Mean stigma scoreMeasured at baseline and endline (after 2 months gap from baseline)

Change in mean stigma score using Cancer Stigma Scale at baseline and follow up

Secondary Outcome Measures
NameTimeMethod
Cervical cancer screening uptakeMeasured within a month after endline

Number of women attending cervical cancer screening program in intervention and control groups

Trial Locations

Locations (1)

Budanilkantha Municipality

🇳🇵

Kathmandu, Province-3, Nepal

© Copyright 2025. All Rights Reserved by MedPath